Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Tolley

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Rheumatology (Oxford, England)|January 17, 2002
A nurse-delivered advice intervention can reduce chronic non-steroidal anti-inflammatory drug use in general practice: a randomized controlled trialA C Jones, L Coulson, K Muir, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost-Effectiveness of Dapagliflozin Versus Dpp-4 Inhibitors as Monotherapy in the Treatment of Type 2 Diabetes Mellitus From A Uk Health Care PerspectiveM Charokopou, H Vioix, B Verheggen, et al.
BMC Health Services Research|November 7, 2015
Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System PerspectiveM Charokopou, P McEwan, S Lister, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 31, 2015
The cost-effectiveness of dapagliflozin versus sulfonylurea as an add-on to metformin in the treatment of Type 2 diabetes mellitusM Charokopou, P McEwan, S Lister, et al.
Health Technology Assessment (Winchester, England)|October 25, 2000
The effectiveness of domiciliary health visiting: a systematic review of international studies and a selective review of the British literatureR Elkan, D Kendrick, M Hewitt, et al.
Journal of Evolutionary Biology|February 4, 2012
Phenotypic and genetic divergence among harbour porpoise populations associated with habitat regions in the North Sea and adjacent seasCarlos J De Luna, S J Goodman, O Thatcher, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 29, 2013
Treatment for life for severe haemophilia A- A cost-utility model for prophylaxis vs. on-demand treatmentA Farrugia, J Cassar, M C Kimber, et al.
British Journal of Cancer|January 1, 1997
Continued inadequacies in data sources for the evaluation of cancer servicesS J Smith, K R Muir, J L Wolstenholme, et al.
Journal of Chemotherapy (Florence, Italy)|May 23, 2002
The application of cost effectiveness analysis to derive a formulary for urinary tract infectionsA Tramarin, L Bragagnolo, K Tolley, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2002
Continued utilization and costs of proton pump inhibitors after Helicobacter pylori eradication in chronic users of gastrointestinal drugsR M Klok, J R B J Brouwers, P B Van den Berg, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Rheumatology (Oxford, England)|January 17, 2002
A nurse-delivered advice intervention can reduce chronic non-steroidal anti-inflammatory drug use in general practice: a randomized controlled trialA C Jones, L Coulson, K Muir, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost-Effectiveness of Dapagliflozin Versus Dpp-4 Inhibitors as Monotherapy in the Treatment of Type 2 Diabetes Mellitus From A Uk Health Care PerspectiveM Charokopou, H Vioix, B Verheggen, et al.
BMC Health Services Research|November 7, 2015
Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System PerspectiveM Charokopou, P McEwan, S Lister, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 31, 2015
The cost-effectiveness of dapagliflozin versus sulfonylurea as an add-on to metformin in the treatment of Type 2 diabetes mellitusM Charokopou, P McEwan, S Lister, et al.
Health Technology Assessment (Winchester, England)|October 25, 2000
The effectiveness of domiciliary health visiting: a systematic review of international studies and a selective review of the British literatureR Elkan, D Kendrick, M Hewitt, et al.
Journal of Evolutionary Biology|February 4, 2012
Phenotypic and genetic divergence among harbour porpoise populations associated with habitat regions in the North Sea and adjacent seasCarlos J De Luna, S J Goodman, O Thatcher, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 29, 2013
Treatment for life for severe haemophilia A- A cost-utility model for prophylaxis vs. on-demand treatmentA Farrugia, J Cassar, M C Kimber, et al.
British Journal of Cancer|January 1, 1997
Continued inadequacies in data sources for the evaluation of cancer servicesS J Smith, K R Muir, J L Wolstenholme, et al.
Journal of Chemotherapy (Florence, Italy)|May 23, 2002
The application of cost effectiveness analysis to derive a formulary for urinary tract infectionsA Tramarin, L Bragagnolo, K Tolley, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2002
Continued utilization and costs of proton pump inhibitors after Helicobacter pylori eradication in chronic users of gastrointestinal drugsR M Klok, J R B J Brouwers, P B Van den Berg, et al.
Pageof 6